These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1029986

  • 21. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF, Russell GI, Swales JD, Thurston H.
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [Abstract] [Full Text] [Related]

  • 22. The renin-angiotensin-aldosterone system in patients with nephrotic syndrome: effects of 1-sar-8-ala-angiotensin II.
    Düsing R, Vetter H, Kramer HJ.
    Nephron; 1980 Aug; 25(4):187-92. PubMed ID: 6990285
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Saralasin infusion in renovascular and essential hypertension.
    Thien T, Hoefnagels WH.
    Neth J Med; 1980 Aug; 23(2):68-73. PubMed ID: 6990282
    [No Abstract] [Full Text] [Related]

  • 25. [Effect of saralasin on plasma renin activity and arginine-vasopressin in patients with angiotensin-dependent hypertension (author's transl)].
    Arlart IP, Wagner H, Rosenthal J.
    Klin Wochenschr; 1978 Jun 15; 56(12):625-7. PubMed ID: 682528
    [Abstract] [Full Text] [Related]

  • 26. Role of renin-angiotensin system in experimental hypertension in rats: plasma renin and hypotensive effect of angiotensin II antagonist.
    Yamamoto J.
    Jpn Circ J; 1977 Jun 15; 41(6):665-75. PubMed ID: 886656
    [No Abstract] [Full Text] [Related]

  • 27. [The saralasin test in clinical evaluation of hypertensive states].
    Cremoncini C, Cremoncini M, Libroia A, Vignati E, Botalla L.
    Boll Soc Ital Cardiol; 1978 Jun 15; 23(8):1291-7. PubMed ID: 398708
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of the biological effects of two angiotensin II analogues in hypertensive patients with sodium depletion.
    Hata T, Ogihara T, Mikami H, Nakamaru M, Maruyama A, Mandai T, Kumahara Y.
    Life Sci; 1978 Jun 05; 22(21):1955-62. PubMed ID: 672437
    [No Abstract] [Full Text] [Related]

  • 29. [Proceedings: Study on participation of renin-angiotensin system in various types of hypertension by clinical application of an angiotensin II analogue (1-sar, 8-Ile-angiotensin II)].
    Ogiwara T, Miyai K, Kumabara Y, Yamamoto T, Omori K.
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb 20; 50(2):436. PubMed ID: 4375586
    [No Abstract] [Full Text] [Related]

  • 30. Renin, blood volume and response to saralasin in patients on chronic haemodialysis: evidence against volume- and renin-'dependent' hypertension.
    McGrath BP, Ledingham JG.
    Clin Sci Mol Med; 1978 Mar 20; 54(3):305-12. PubMed ID: 630806
    [No Abstract] [Full Text] [Related]

  • 31. [Action of 1-sar-8-ala-angiotensin II (saralasin) on the feedback mechanism between renin and angiotensin II].
    Ochs HG, Brass H, Lamberts G, Heintz R.
    Verh Dtsch Ges Kreislaufforsch; 1977 Mar 20; 43():193-4. PubMed ID: 613566
    [No Abstract] [Full Text] [Related]

  • 32. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
    Fagard R, Amery A, Lijnen P, Reybrouck T.
    Eur J Clin Invest; 1977 Dec 20; 7(6):473-9. PubMed ID: 415868
    [Abstract] [Full Text] [Related]

  • 33. Renal vascular responses to infusions of 1-sarcosine-8-alanine-angiotensin II (saralasin) in man and dog [proceedings].
    Lewis PS, Wilcox CS.
    J Physiol; 1978 Jul 20; 280():42P-43P. PubMed ID: 690897
    [No Abstract] [Full Text] [Related]

  • 34. Effects of angiotensin II and 1-Sar-8-Ala-angiotensin II on the renal function in sodium-replete and -deplete dogs [proceedings].
    Lijnen PJ, Fagard RH, Amery AK.
    Arch Int Physiol Biochim; 1979 Feb 20; 87(1):193-4. PubMed ID: 92269
    [No Abstract] [Full Text] [Related]

  • 35. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N, Madeddu P, Dessì-Fulgheri P, Meloni F, Palermo M, Fiori C, Rappelli A.
    Boll Soc Ital Cardiol; 1980 Feb 20; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract] [Full Text] [Related]

  • 36. The effect of angiotensin II blockade by saralasin (1-Sar-8-Ala-angiotensin II) in normal man.
    Ibsen H, Kappelgaard AM, Nielsen MD, Giese J.
    Eur J Clin Pharmacol; 1978 Nov 27; 14(3):171-6. PubMed ID: 729612
    [No Abstract] [Full Text] [Related]

  • 37. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET, Stinson J, Ramirez G.
    Postgrad Med; 1980 Oct 27; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [Abstract] [Full Text] [Related]

  • 38. [Significance of renin-angiotensin system inhibitors in the diagnosis of hypertension].
    Stumpe KO, Kolloch RE, Overlack A.
    Med Welt; 1977 Oct 14; 28(41):1645-9. PubMed ID: 927124
    [No Abstract] [Full Text] [Related]

  • 39. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.
    Atlas SA, Volpe M, Sosa RE, Laragh JH, Camargo MJ, Maack T.
    Fed Proc; 1986 Jun 14; 45(7):2115-21. PubMed ID: 2940120
    [Abstract] [Full Text] [Related]

  • 40. Rebound hypertensive after sodium nitroprusside prevented by saralasin in rats.
    Delaney TJ, Miller ED.
    Anesthesiology; 1980 Feb 14; 52(2):154-6. PubMed ID: 7352670
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.